289 results match your criteria: "Lyon Sud University Hospital[Affiliation]"
Contact Dermatitis
December 2024
Dermatology, Allergology and Photobiology Department, Grenoble University Hospital, Grenoble, France.
Ann Dermatol Venereol
December 2024
Dermatology Department, Edouard Herriot University Hospital, Lyon, France; Dermatology Department, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France.
Dig Liver Dis
December 2024
Department of Gastroenterology and Digestive Oncology, Reims University Hospital, Reims, France.
Background: This article summarizes the French intergroup guidelines regarding rectal adenocarcinoma (RA) management published in September 2023, available on the French Society of Gastroenterology website.
Methods: This work was supervised by French medical and surgical societies involved in RA management. Recommendations were rated from A to C according to the literature until September 2023.
Ann Surg Oncol
December 2024
Department of Digestive Surgery, Begin Military Teaching Hospital, Saint Mandé, France.
Proc Natl Acad Sci U S A
December 2024
School of Medical Sciences, Faculty of Medicine and Health, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2006, Australia.
Recent discoveries have revealed that genetic variants in γ-aminobutyric acid type A (GABA) receptor subunits can lead to both gain-of-function (GOF) and loss-of-function (LOF) receptors. GABA receptors, however, have a pseudosymmetrical pentameric assembly, and curiously diverse functional outcomes have been reported for certain homologous variants in paralogous genes (paralogous variants). To investigate this, we assembled a cohort of 11 individuals harboring paralogous M1 proline missense variants in , , and Seven mutations (α1, α1, β2, β3, β3, γ2, and γ2) in α1β2/3γ2 receptors were analyzed using electrophysiological examinations and molecular dynamics simulations.
View Article and Find Full Text PDFKidney Med
December 2024
Centre for Research in Epidemiology and Population Health, Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France.
Ann Surg Oncol
November 2024
Department of Digestive and Emergency Surgery, Grenoble-Alpes University Hospital, Grenoble, France.
Eur Radiol
November 2024
Netherlands Cancer Institute, Department of Radiology, 1066 CX, Amsterdam, The Netherlands.
Ann Surg Oncol
January 2025
Department of Digestive Surgery, Begin Military Teaching Hospital, Saint Mandé, France.
J Am Acad Dermatol
October 2024
Dermatology Department, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address:
Eur Radiol
October 2024
Department of Radiology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Bénite, France.
Severe cutaneous adverse reactions to drugs (SCARs) are rare but life-threatening delayed allergies. While they primarily affect the skin, they can also affect internal organs. Accordingly, they present with diverse clinical symptoms that vary not only between SCARs subtypes but also among patients.
View Article and Find Full Text PDFInt J Gynaecol Obstet
January 2025
Department of Surgery, Americain Hopsital of Paris, Neuilly sur seine, France.
Endometriosis is a complex gynecologic disorder characterized primarily by symptoms of pelvic pain, infertility, and altered quality of life. National and international guidelines highlight the diagnostic difficulties and lack of conclusive diagnostic tools for endometriosis. Furthermore, guidelines are becoming questionable at an increasingly rapid rate as new diagnostic techniques emerge.
View Article and Find Full Text PDFBackground: We evaluated co-administration of adjuvanted seasonal quadrivalent influenza vaccine (FLU-aQIV) and respiratory syncytial virus (RSV) prefusion F protein-based vaccine (RSVPreF3 OA) in ≥65-year-olds.
Methods: This phase 3, open-label trial randomized ≥65-year-olds to receive FLU-aQIV and RSVPreF3 OA concomitantly (Co-Ad) or sequentially, 1 month apart (Control). Primary objectives were to demonstrate the non-inferiority of FLU-aQIV and RSVPreF3 OA co-administration versus sequential administration in terms of hemagglutination inhibition (HI) titers for each FLU-aQIV strain and RSV-A and RSV-B neutralization titers, 1 month post-vaccination.
J Gynecol Obstet Hum Reprod
November 2024
Gynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, APHP Centre, 20, rue Leblanc 75908 Paris Cedex 15, Paris, France; INSERM UMR-S 1147, University of Paris Cité, Centre de Recherche des Cordeliers, Paris, France.
ESMO Open
August 2024
The Unit of Molecular Pathology, INSERM 1052, CNRS 5286 of Cancer Research Center of Lyon, and Team Genetics, Epigenetics and Biology of Sarcomas, Université Claude Bernard Lyon 1, Lyon; Department of Biopathology, CNR MESOPATH NETMESO, CLCC UNICANCER Leon Berard, Lyon; University Grenoble Alpes, Grenoble, France.
Background: Mesothelioma is a rare and aggressive malignant neoplasm arising from mesothelial cells, which occasionally manifests recurrent fusions. EWSR1/FUS-CREB, YY1, MAP3K8, NR4A3, and ALK-rearranged proliferations have been reported in limited series with no clear histological or clinical correlations, limiting clinicians' ability to assess prognosis and integrate these new entities into therapeutic decisions. The aim of this study was to better characterize these rearranged proliferations histologically, molecularly, and clinically.
View Article and Find Full Text PDFAnn Surg
July 2024
Department of General Surgery and Surgical Oncology, Lyon Sud University Hospital, Pierre Benite, France.
Objective: To analyze the reasons for stopping pressurized intraperitoneal aerosolized chemotherapy (PIPAC) delivered for unresectable peritoneal surface malignancies (PSM) and to determine survival in a large patient cohort of an experienced PIPAC center.
Background: PIPAC alone or combined with systemic chemotherapy was developed to palliatively treat unresectable PSM. Safety, tolerance and promising survival results were already reported, but the reasons for stopping treatment remain unclear and the influence of the number of PIPAC procedures on prognosis has not been evaluated.
Int J Gynaecol Obstet
November 2024
University Claude Bernard of Lyon 1, EMR 3738 CICLY, Lyon, France.
Fr J Urol
November 2024
Urology Department, Rennes University Hospital, Rennes, France.
Introduction: The Operated Male-to-Female Sexual Function Index (oMtFSFI) questionnaire is the first scoring system developed to assess sexual function after gender-affirming vulvo-vaginoplasty, and was initially developed and validated in Italian. The aim of this study was to provide linguistic validation of the questionnaire in French through several steps including use of the questionnaires across a series of patients who had undergone gender-affirming vulvo-vaginoplasty between 2020 and 2022 at two French academic centers.
Method: The French version of the oMtFSFI questionnaire was obtained through a double translation (Italian to French) and a back-translation (French to Italian), validated by a scientific committee, and cognitively assessed by a panel of expert patients.
Eur Radiol
December 2024
Department of Radiology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Bénite, France.
Tech Coloproctol
July 2024
Colorectal Unit, Department of Surgery, Grenoble Alpes University Hospital, 38000, Grenoble, France.
Background: Bladder drainage is systematically used in rectal cancer surgery; however, the optimal type of drainage, transurethral catheterization (TUC) or suprapubic catheterization (SPC), is still controversial. The aim was to compare the rates of urinary tract infection on the fourth postoperative day (POD4) between TUC and SPC, after rectal cancer surgery regardless of the day of removal of the urinary drain.
Methods: This randomized clinical trial in 19 expert colorectal surgery centers in France and Belgium was performed between October 2016 and October 2019 and included 240 men (with normal or subnormal voiding function) undergoing mesorectal excision with low anastomosis for rectal cancer.
Clin Exp Dermatol
November 2024
Dermatology Department, Edouard Herriot University Hospital, Hospices Civils de Lyon, Lyon, France.
Lung Cancer
July 2024
Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Imaging continues to gain a greater role in the assessment and clinical management of patients with mesothelioma. This communication summarizes the oral presentations from the imaging session at the 2023 International Conference of the International Mesothelioma Interest Group (iMig), which was held in Lille, France from June 26 to 28, 2023. Topics at this session included an overview of best practices for clinical imaging of mesothelioma as reported by an iMig consensus panel, emerging imaging techniques for surgical planning, radiologic assessment of malignant pleural effusion, a radiomics-based transfer learning model to predict patient response to treatment, automated assessment of early contrast enhancement, and tumor thickness for response assessment in peritoneal mesothelioma.
View Article and Find Full Text PDFCPT Pharmacometrics Syst Pharmacol
July 2024
Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hôpital, Lyon, France.
The recent SarsCov2 pandemic has disrupted healthcare system notably impacting intensive care units (ICU). In severe cases, the immune system is dysregulated, associating signs of hyperinflammation and immunosuppression. In the present work, we investigated, using a joint modeling approach, whether the trajectories of cellular immunological parameters were associated with survival of COVID-19 ICU patients.
View Article and Find Full Text PDFKidney Int Rep
April 2024
Pediatric Rheumatology - Nephrology and Dermatology Unit, Hôpital Femme Mère Enfant, Hospices, Civils de Lyon, Bron, France.